2018 related articles for article (PubMed ID: 15850953)
41. [Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays].
Lutteri L; Sagot C; Chapelle JP
Ann Biol Clin (Paris); 2010; 68(2):149-56. PubMed ID: 20348047
[TBL] [Abstract][Full Text] [Related]
42. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
[TBL] [Abstract][Full Text] [Related]
43. Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay.
Bargou I; Mankaï A; Jamaa A; Ben Jazia I; Skandrani K; Sfar H; Baccouche A; Ajmi S; Letaief A; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2008 Feb; 56(1):10-4. PubMed ID: 17604571
[TBL] [Abstract][Full Text] [Related]
44. [Anti-endomysium, anti-reticulin and anti-gliadin antibodies in the diagnosis of coeliac disease in adults].
Ghedira I; Sghiri R; Yacoubi MT; Korbi S; Jeddi M
Ann Biol Clin (Paris); 1999; 57(6):717-9. PubMed ID: 10572222
[No Abstract] [Full Text] [Related]
45. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.
Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961
[TBL] [Abstract][Full Text] [Related]
46. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study.
Simell S; Hoppu S; Hekkala A; Simell T; Ståhlberg MR; Viander M; Yrjänäinen H; Grönlund J; Markula P; Simell V; Knip M; Ilonen J; Hyöty H; Simell O
Am J Gastroenterol; 2007 Sep; 102(9):2026-35. PubMed ID: 17573785
[TBL] [Abstract][Full Text] [Related]
47. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
[TBL] [Abstract][Full Text] [Related]
48. ELISA of anti-endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti-endomysial antibodies and tissue transglutaminase antibodies.
Shamir R; Eliakim R; Lahat N; Sobel E; Lerner A
Isr Med Assoc J; 2002 Aug; 4(8):594-6. PubMed ID: 12183862
[TBL] [Abstract][Full Text] [Related]
49. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy.
Lock RJ; Pitcher MC; Unsworth DJ
J Clin Pathol; 1999 Apr; 52(4):274-7. PubMed ID: 10474519
[TBL] [Abstract][Full Text] [Related]
50. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
51. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
52. Tissue transglutaminase antibodies in celiac disease.
Biagi F; Ellis HJ; Yiannakou JY; Brusco G; Swift GL; Smith PM; Corazza GR; Ciclitira PJ
Am J Gastroenterol; 1999 Aug; 94(8):2187-92. PubMed ID: 10445548
[TBL] [Abstract][Full Text] [Related]
53. IgA antibodies against endomysium and transglutaminase: a comparison of methods.
Jaskowski TD; Schroder C; Martins TB; Litwin CM; Hill HR
J Clin Lab Anal; 2001; 15(3):108-11. PubMed ID: 11344523
[TBL] [Abstract][Full Text] [Related]
54. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods.
Reeves GE; Burns C; Hall ST; Gleeson M; Lemmert K; Clancy RL
Pathology; 2000 Aug; 32(3):181-5. PubMed ID: 10968391
[TBL] [Abstract][Full Text] [Related]
55. IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease.
West J; Lloyd CA; Hill PG; Holmes GK
Clin Lab; 2002; 48(5-6):241-6. PubMed ID: 12071574
[TBL] [Abstract][Full Text] [Related]
56. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome.
Shamaly H; Hartman C; Pollack S; Hujerat M; Katz R; Gideoni O; Shamir R
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):583-6. PubMed ID: 17460490
[TBL] [Abstract][Full Text] [Related]
57. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
[TBL] [Abstract][Full Text] [Related]
58. Increased prevalence of anti-gliadin antibodies and anti-tissue transglutaminase antibodies in children with cerebral palsy.
Stenberg R; Dahle C; Lindberg E; Schollin J
J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):424-9. PubMed ID: 19590452
[TBL] [Abstract][Full Text] [Related]
59. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease.
Sulkanen S; Halttunen T; Laurila K; Kolho KL; Korponay-Szabó IR; Sarnesto A; Savilahti E; Collin P; Mäki M
Gastroenterology; 1998 Dec; 115(6):1322-8. PubMed ID: 9834257
[TBL] [Abstract][Full Text] [Related]
60. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease.
Sugai E; Vázquez H; Nachman F; Moreno ML; Mazure R; Smecuol E; Niveloni S; Cabanne A; Kogan Z; Gómez JC; Mauriño E; Bai JC
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1112-7. PubMed ID: 16860613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
